Does vascular surgery cost too much?

Journal of Vascular Surgery

Volumn 50, Issue 5, 2009, Pages 1211-1218

  Clagett, G Patrick ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEALTH CARE COST; MEDICAID; MEDICARE; PRIORITY JOURNAL; VASCULAR DISEASE; VASCULAR SURGERY;

BUDGETS; COST SAVINGS; COST-BENEFIT ANALYSIS; FINANCING, GOVERNMENT; GOVERNMENT REGULATION; HEALTH CARE COSTS; HEALTH CARE REFORM; HEALTH EXPENDITURES; HEALTH POLICY; HEALTH SERVICES RESEARCH; HEALTHCARE DISPARITIES; HUMANS; MEDICAID; MEDICARE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR DISEASES; VASCULAR SURGICAL PROCEDURES;

EID: 70350569277     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.06.063     Document Type: Editorial

References (25)

1. Johnston K.W. The Society for Vascular Surgery - State of the Society, 2008. J Vasc Surg 48 (2008) 1613-1619
2. US National Debt Clock. http://www.usdebtclock.org Accessed March 17, 2009.
3. Keehan S., Sisko A., Tuffer C., Smith S., Cowan C., Poisal J., et al. Health spending projections through 2017: the baby-boom generation is coming to Medicare. Health Aff 27 (2008) w145-w155
4. Hartman M., Catlin A., Lasman D., Cylus J., and Heffler S. US health spending by age, selected years through 2004. Health Aff 27 (2008) w1-w12
5. Health care spending - UC atlas of global inequality. http://ucatlas.ucsc.edu/spend.php Accessed on February 10, 2009.
6. In: Wennberg J., Fisher E., Goodman D., and Skinner J. (Eds). Tracking the care of patients with severe chronic illness: The Dartmouth atlas of health care 2008 (2008), The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, (NH)
7. Sirovich B., Gallagher P., Wennberg D., and Fisher E. Discretionary decision making by primary care physicians and the cost of US health care. Health Aff 27 (2008) 813-823
8. Fisher E., Bynum J., and Skinner J. Slowing the growth of health care costs - lessons from regional variation. N Engl J Med 360 (2009) 849-852
9. Dartmouth - CMS - FDA collaborative. Trends and regional variations in abdominal aortic aneurysm repair (February 1, 2006). http://www.dartmouthatlas.org/atlases/AAA_report_2006.pdf Accessed March 2009.
10. Gawande A. Annals of medicine - The cost conundrum: What a Texas town can teach us about health care. The New Yorker (June 1, 2009). http://www.newyorker.com/reporting/2009/06/01/090601fa_fact_gawande Accessed June 1, 2009.
11. CBO paper. Research on the comparative effectiveness of medical treatments: Issues and options for an expanded federal role (December 2007). http://www.cbo.gov/ftpdocs/88xx/doc8891/12-18-ComparativeEffectiveness.pdf Accessed March 2009.
12. Gibbons R., Gardner T., Anderson J., Goldstein L., Meltzer N., Weintraub W., et al. The American Heart Association's principles for comparative effectiveness research - policy statement from the American Heart Association. Circulation 119 (2009) 2955-2962
13. Slutsky J., Atkins D., Chang S., and Sharp B. Comparing medical interventions: AHRQ and the effective health care program. J Clin Epidemiol (June 2008) Sept 30;[Epublication ahead of print].
14. Steinbrook R. Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence. N Engl J Med 359 (2008) 19
15. NHS. NICE technology appraisal guidance 167. Endovascular stent grafts for the treatment of abdominal aortic aneurysms (February 2009). http://www.nice.org.uk/nicemedia/pdf/TA167Guidance.pdf Accessed February 2009.
16. DeMaria A. Comparative effectiveness research. J Am Coll Cardiol 53 (2009) 973-975
17. Garber A., and Tunis S. Does comparative-effectiveness research threaten personalized medicine?. N Engl J Med 360 (2009) 1925-1927
18. Sidawy A., Zwolak R., White R., Simami F., Schermerhorn M., and Sicard G. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry. J Vasc Surg 49 (2009) 71-79
19. Ad Hoc Task Force. Comparative effectiveness and vascular surgery. J Vasc Surg (2009) (in press).
20. Spronk S., Bosch J., den Hoed P., Veen H., Pattynama P., and Hunink M. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg 48 (2008) 1472-1480
21. Greenhalgh R., Belch J., Brown L., Gaines P., Gao L., Reise J., et al. The MIMIC Trial Participants. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice, and best medical therapy: results from two randomized trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 36 (2008) 680-688
22. Spronk S., Bosch J., den Hoed P., Veen H., Pattynama P., and Hunink M. Intermittent claudication: clinical effectiveness of endovascular revascularization vs supervised hospital-based exercise training randomized controlled trial. Radiology 250 (2009) 586-595
23. Pear R. US to compare medical treatments. New York Times. http://www.nytimes.com/2009/02/16/health/policy/16health.html?hp Accessed February 16, 2009.
24. Clagett G.P. EVAR, TEVAR, FEVAR, too far?. Perspectives Vasc Surg Endovasc Ther 20 (2008) 115-119
25. Hertzer N. Presidential address: outcome assessment in vascular surgery - results mean everything. J Vasc Surg 21 (1995) 6-15